AT399655B - Verfahren zur herstellung einer multivalenten pneumokokkenvakzine - Google Patents

Verfahren zur herstellung einer multivalenten pneumokokkenvakzine

Info

Publication number
AT399655B
AT399655B AT0109085A AT109085A AT399655B AT 399655 B AT399655 B AT 399655B AT 0109085 A AT0109085 A AT 0109085A AT 109085 A AT109085 A AT 109085A AT 399655 B AT399655 B AT 399655B
Authority
AT
Austria
Prior art keywords
pneumocock
multivalent
vaccine
producing
pneumocock vaccine
Prior art date
Application number
AT0109085A
Other languages
English (en)
Other versions
ATA109085A (de
Inventor
Mary B Ritchey
Francis R Cano
Gerald J O'hara
James D English
Wenlii Lin
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of ATA109085A publication Critical patent/ATA109085A/de
Application granted granted Critical
Publication of AT399655B publication Critical patent/AT399655B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/831—Drug, bio-affecting and body treating compositions involving capsular polysaccharide of bacterium, e.g. polyribosyl ribitol phosphate

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
AT0109085A 1984-04-12 1985-04-11 Verfahren zur herstellung einer multivalenten pneumokokkenvakzine AT399655B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/599,318 US4686102A (en) 1984-04-12 1984-04-12 Multivalent pneumococcal vaccine and preparation thereof

Publications (2)

Publication Number Publication Date
ATA109085A ATA109085A (de) 1994-11-15
AT399655B true AT399655B (de) 1995-06-26

Family

ID=24399151

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0109085A AT399655B (de) 1984-04-12 1985-04-11 Verfahren zur herstellung einer multivalenten pneumokokkenvakzine

Country Status (9)

Country Link
US (1) US4686102A (de)
EP (1) EP0157899B1 (de)
JP (1) JPH0641422B2 (de)
AT (1) AT399655B (de)
AU (1) AU569946B2 (de)
CA (1) CA1216235A (de)
DE (1) DE3485778T2 (de)
ES (1) ES533263A0 (de)
ZA (1) ZA852724B (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4877613A (en) * 1987-08-05 1989-10-31 Biotech Connections, Inc. Process for preparing veterinary acellular vaccines against gram-negative nonenteric pathogenic bacilli
CA2059692C (en) * 1991-01-28 2004-11-16 Peter J. Kniskern Pneumoccoccal polysaccharide conjugate vaccine
CA2059693C (en) * 1991-01-28 2003-08-19 Peter J. Kniskern Polysaccharide antigens from streptococcus pneumoniae
US5314811A (en) * 1992-07-13 1994-05-24 Merck & Co., Inc. Process for converting lipid-containing bacterial capsular polysaccharide into lipid-free polysaccharide
US5371197A (en) * 1991-09-24 1994-12-06 Merck & Co., Inc. Protein-dimeric polysaccharide conjugate vaccine
US5314822A (en) * 1992-10-15 1994-05-24 Merck & Co., Inc. Method of clonal growth of Streptococcus pneumoniae
US5565204A (en) * 1994-08-24 1996-10-15 American Cyanamid Company Pneumococcal polysaccharide-recombinant pneumolysin conjugate vaccines for immunization against pneumococcal infections
US5714354A (en) * 1995-06-06 1998-02-03 American Home Products Corporation Alcohol-free pneumococcal polysaccharide purification process
DK0897427T3 (da) * 1996-02-14 2005-02-14 Merck & Co Inc Fremgangsmåde til fældning af polysaccharid
US6410025B1 (en) 1996-02-14 2002-06-25 Merck & Co., Inc. Polysaccharide precipitation process
US6224880B1 (en) 1997-09-24 2001-05-01 Merck & Co., Inc. Immunization against Streptococcus pneumoniae using conjugated and unconjugated pneumoccocal polysaccharide vaccines
US7144989B2 (en) 2002-03-25 2006-12-05 Albert Einstein College Of Medicine Of Yeshiva University Pegylated non-hypertensive hemoglobins, methods of preparing same, and uses thereof
US6737524B2 (en) 2002-03-25 2004-05-18 Paul K. Smith Activated polyethylene glycol compounds
DE602004020459D1 (de) * 2003-02-27 2009-05-20 Glaxo Group Ltd Fondaparinux- natrium zusammenstellung von hoher reinheit
US7320874B2 (en) * 2003-07-08 2008-01-22 Aventis Pasteur Sa Assaying the teichoic acids of gram+ bacteria
EP1928418B1 (de) 2005-09-30 2011-12-21 Lipoxen Technologies Limited Liposomale impfstoff-zusammensetzung aus einem polysaccharid-antigen und einem protein-adjuvans
US8808707B1 (en) 2006-05-08 2014-08-19 Wyeth Llc Pneumococcal dosing regimen
PL2436700T3 (pl) 2007-03-23 2018-12-31 Wyeth Llc Skrócony sposób oczyszczania do wytwarzania polisacharydów otoczkowych Streptococcus pneumoniae
BRPI0810211A2 (pt) 2007-04-13 2014-10-21 Univ Oklahoma Citolisina dependente de colesterol mutante purficada, composição, vacina, método para vacinar um paciente, anticorpo monoclonal, ácido nucléico, e, célula hospedeira.
AU2009335824B2 (en) 2008-12-18 2013-07-04 Wyeth Llc Method for controlling Streptococcus pneumoniae polysaccharide molecular weight using carbon
CN102257155B (zh) * 2008-12-18 2016-03-02 惠氏有限责任公司 控制肺炎链球菌血清型19a多糖分子量的方法
CA2900008C (en) 2013-02-07 2025-10-07 Children's Medical Center Corporation PROTEIN ANTIGENS THAT CONFER PROTECTION AGAINST COLONIZATION AND/OR PNEUMOCOCCAL DISEASE
US11160855B2 (en) 2014-01-21 2021-11-02 Pfizer Inc. Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
MX371453B (es) * 2014-01-21 2020-01-29 Pfizer Polisacaridos capsulares de streptococcus pneumoniae y conjugados de los mismos.
CA3206112A1 (en) * 2014-01-21 2015-07-30 Pfizer Inc. Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
EP3220937B1 (de) 2014-11-21 2024-09-04 The Board of Regents of the University of Oklahoma Pneumolysinmutanten und verfahren zur verwendung davon
EP3325008B1 (de) * 2015-07-21 2025-09-10 Pfizer Inc. Immunogene zusammensetzungen mit konjugierten kapselsaccharid-antigenen, kits damit und verwendungen davon
EP4488286A3 (de) 2016-03-31 2025-04-02 Pogona, Llc Saccharid-polypeptid-konjugat-zusammensetzungen und verfahren zu ihrer verwendung
WO2018144799A1 (en) 2017-02-03 2018-08-09 SCHADECK, Eva, Barbara Haemophilus influenzae saccharide-carrier conjugate compositions and uses thereof
CA3062399A1 (en) 2017-05-05 2018-11-08 Serum Institute Of India Private Limited Method for removal of impurities from bacterial capsular polysaccharide based preparations
EP3634481A4 (de) 2017-06-10 2021-07-21 Inventprise, LLC. Multivalente konjugatimpfstoffe mit bivalenten oder multivalenten konjugierten polysacchariden, die verbesserte immunogenität und avidität bereitstellen
US10729763B2 (en) 2017-06-10 2020-08-04 Inventprise, Llc Mixtures of polysaccharide-protein pegylated compounds
WO2019070994A1 (en) 2017-10-04 2019-04-11 Liffey Biotech Limited SACCHARIDE-POLYPEPTIDE CONJUGATE COMPOSITIONS AND METHODS OF USE
WO2022035816A1 (en) 2020-08-10 2022-02-17 Inventprise, Llc Multivalent pneumococcal glycoconjugate vaccines containing emerging serotype 24f
CN116693706B (zh) * 2022-02-24 2024-10-11 成都生物制品研究所有限责任公司 一种肺炎链球菌荚膜多糖的纯化方法
CN116942804A (zh) 2022-04-19 2023-10-27 上海瑞宙生物科技有限公司 多价肺炎球菌多糖结合疫苗的成分及其应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0024493A2 (de) * 1979-08-08 1981-03-11 American Cyanamid Company Multivalenter Pneumokokkenimpfstoff

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1115210A (en) * 1977-11-28 1981-12-29 Dennis J. Carlo Pneumococcal vaccine
BE889979A (fr) * 1981-08-14 1982-02-15 Smith Kline Rit Procede de preparation de polysaccharides bacteriens capsulaires antigeniques purifies, produits obtenus et leur utilisation

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0024493A2 (de) * 1979-08-08 1981-03-11 American Cyanamid Company Multivalenter Pneumokokkenimpfstoff

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ANM. INT. MED. 96(5), 1982, PP. 580-6 *

Also Published As

Publication number Publication date
DE3485778T2 (de) 1993-01-14
DE3485778D1 (de) 1992-07-23
AU4101685A (en) 1985-10-17
ES8602417A1 (es) 1985-12-16
ZA852724B (en) 1985-11-27
ES533263A0 (es) 1985-12-16
ATA109085A (de) 1994-11-15
US4686102A (en) 1987-08-11
JPH0641422B2 (ja) 1994-06-01
JPS60218325A (ja) 1985-11-01
EP0157899A3 (en) 1987-09-09
EP0157899B1 (de) 1992-06-17
CA1216235A (en) 1987-01-06
EP0157899A2 (de) 1985-10-16
AU569946B2 (en) 1988-02-25

Similar Documents

Publication Publication Date Title
AT399655B (de) Verfahren zur herstellung einer multivalenten pneumokokkenvakzine
AT372281B (de) Verfahren zur herstellung einer nutriens-verbindung
ATA26687A (de) Verfahren zur herstellung eines melanom-assoziierten antigens
DE3686350D1 (de) Verfahren zur herstellung einer chirurgischen klammer.
DE3677750D1 (de) Verfahren zur herstellung einer nockenwelle.
ATA11990A (de) Verfahren zur herstellung einer rohrauskleidung
AT399634B (de) Verfahren zur herstellung einer süssware
AT385659B (de) Verfahren zur herstellung einer therapeutischen zusammensetzung
ATA331285A (de) Verfahren zur herstellung einer transmissionsmaske
AT387142B (de) Verfahren zur herstellung einer nitrofurantoin-dosierungsform
DE3141842A1 (de) Verfahren zur herstellung einer drahtverbindung
DD296380A5 (de) Verfahren zur herstellung einer bildroehre
DE3580350D1 (de) Verfahren zur herstellung einer frukto-oligosaccharose.
DE3672928D1 (de) Verfahren zur herstellung einer nachgiebigen walze.
DD148468A3 (de) Verfahren zur herstellung einer bohrspuelung
AT388291B (de) Verfahren zur herstellung einer zahnpasta
DE69031222D1 (de) Verfahren zur herstellung einer 3-substituierten thio-3-cephemverbindung
DE3868669D1 (de) Verfahren zur herstellung einer polyglycidylamin-verbindung.
ATA208784A (de) Verfahren zur herstellung einer neuen kamillensorte (bezeichnung manzana)
DE3685220D1 (de) Verfahren zur herstellung einer abdichtung.
ATA206287A (de) Verfahren zur herstellung einer backware
DE3668428D1 (de) Verfahren zur herstellung einer ziehmatrize.
DE3784961D1 (de) Verfahren zur herstellung einer verbindungsleitung.
ATA189286A (de) Verfahren zur herstellung einer neuen neodymverbindung
DE68904745D1 (de) Verfahren zur herstellung einer walze.

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee